{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:30:27Z","timestamp":1787502627330,"version":"build-2736575974"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2014,9,8]],"date-time":"2014-09-08T00:00:00Z","timestamp":1410134400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0103887","type":"journal-article","created":{"date-parts":[[2014,9,8]],"date-time":"2014-09-08T13:47:24Z","timestamp":1410184044000},"page":"e103887","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":69,"title":["Ginsenoside 20(S)-Rg3 Targets HIF-1\u03b1 to Block Hypoxia-Induced Epithelial-Mesenchymal Transition in Ovarian Cancer Cells"],"prefix":"10.1371","volume":"9","author":[{"given":"Ting","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huilian","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,9,8]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev.pathol.4.110807.092246","article-title":"Ovarian cancer","volume":"4","author":"KR Cho","year":"2009","journal-title":"Annual Review of Pathology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/jnci\/djs203","article-title":"Molecular scores to predict ovarian cancer outcomes: a worthy goal, but not ready for prime time","volume":"104","author":"EM Swisher","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.semradonc.2004.04.008","article-title":"Tumor microenvironmental physiology and its implications for radiation oncology","volume":"14","author":"P Vaupel","year":"2004","journal-title":"Seminars in radiation oncology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/jnci\/93.4.266","article-title":"Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects","volume":"93","author":"M Hockel","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/cdd.2008.12","article-title":"Biology of HIF-1alpha","volume":"15","author":"A Weidemann","year":"2008","journal-title":"Cell Death and Differentiation"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ncb1691","article-title":"Direct regulation of TWIST by HIF-1alpha promotes metastasis","volume":"10","author":"MH Yang","year":"2008","journal-title":"Nature cell biology"},{"key":"ref7","first-page":"1","article-title":"HIF-1, O(2), and the 3 PHDs: how animal cells signal hypoxia to the nucleus","volume":"107","author":"GL Semenza","year":"2001","journal-title":"Cell"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1059796","article-title":"Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation","volume":"292","author":"P Jaakkola","year":"2001","journal-title":"Science"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1089\/152308603768295212","article-title":"HIF-1 in cell cycle regulation, apoptosis, and tumor progression","volume":"5","author":"N Goda","year":"2003","journal-title":"Antioxidants & redox signaling"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/28867","article-title":"Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis","volume":"394","author":"P Carmeliet","year":"1998","journal-title":"Nature"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e53070","DOI":"10.1371\/journal.pone.0053070","article-title":"VEGF, HIF-1alpha expression and MVD as an angiogenic network in familial breast cancer","volume":"8","author":"C Saponaro","year":"2013","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ccr.2007.07.006","article-title":"HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation","volume":"12","author":"JD Gordan","year":"2007","journal-title":"Cancer Cell"},{"key":"ref13","first-page":"3810","article-title":"Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition","volume":"117","author":"DF Higgins","year":"2007","journal-title":"The Journal of clinical investigation"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10911-010-9178-9","article-title":"Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression","volume":"15","author":"DS Micalizzi","year":"2010","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ki.2009.222","article-title":"Oxygen regulates epithelial-to-mesenchymal transition: insights into molecular mechanisms and relevance to disease","volume":"76","author":"VH Haase","year":"2009","journal-title":"Kidney Int"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"8319","DOI":"10.1158\/0008-5472.CAN-06-0410","article-title":"Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis","volume":"66","author":"JJ Christiansen","year":"2006","journal-title":"Cancer Research"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e74923","DOI":"10.1371\/journal.pone.0074923","article-title":"FHOD1, a Formin Upregulated in Epithelial-Mesenchymal Transition, Participates in Cancer Cell Migration and Invasion","volume":"8","author":"M Gardberg","year":"2013","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrm1835","article-title":"Complex networks orchestrate epithelial-mesenchymal transitions","volume":"7","author":"JP Thiery","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e66558","DOI":"10.1371\/journal.pone.0066558","article-title":"SNAI1-mediated epithelial-mesenchymal transition confers chemoresistance and cellular plasticity by regulating genes involved in cell death and stem cell maintenance","volume":"8","author":"S Lim","year":"2013","journal-title":"PLoS One"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.2353\/ajpath.2009.080545","article-title":"Epithelial-mesenchymal transition: a cancer researcher's conceptual friend and foe","volume":"174","author":"MW Klymkowsky","year":"2009","journal-title":"The American journal of pathology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1038\/onc.2010.215","article-title":"EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer","volume":"29","author":"A Singh","year":"2010","journal-title":"Oncogene"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-2952(97)00193-7","article-title":"Panax ginseng pharmacology: a nitric oxide link?","volume":"54","author":"CN Gillis","year":"1997","journal-title":"Biochemical pharmacology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1006\/exnr.2001.7841","article-title":"Neuroprotective effects of ginseng total saponin and ginsenosides Rb1 and Rg1 on spinal cord neurons in vitro","volume":"173","author":"B Liao","year":"2002","journal-title":"Experimental neurology"},{"key":"ref24","first-page":"25","article-title":"Ginsenosides as Anticancer Agents: In vitro and in vivo Activities, Structure-Activity Relationships, and Molecular Mechanisms of Action","volume":"3","author":"SA Nag","year":"2012","journal-title":"Front Pharmacol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2174\/157016109788340767","article-title":"Ginseng compounds: an update on their molecular mechanisms and medical applications","volume":"7","author":"JM Lu","year":"2009","journal-title":"Curr Vasc Pharmacol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jgr.2013.11.014","article-title":"AMP-activated protein kinase: An emerging target for ginseng","volume":"38","author":"KJ Jeong","year":"2014","journal-title":"J Ginseng Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.3892\/ijmm.2013.1519","article-title":"Biochemical basis of cancer chemoprevention and\/or chemotherapy with ginsenosides (Review)","volume":"32","author":"JS Choi","year":"2013","journal-title":"Int J Mol Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.7314\/APJCP.2014.15.6.2453","article-title":"Ginsenoside Rg1 induces apoptosis through inhibition of the EpoR-mediated JAK2\/STAT5 signalling pathway in the TF-1\/Epo human leukemia cell line","volume":"15","author":"J Li","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1271\/bbb.80637","article-title":"Proteomic analysis of the anti-cancer effect of 20S-ginsenoside Rg3 in human colon cancer cell lines","volume":"73","author":"SY Lee","year":"2009","journal-title":"Bioscience, biotechnology, and biochemistry"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1248\/bpb.18.1197","article-title":"Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)- and 20(S)-ginsenoside-Rg3, of red ginseng","volume":"18","author":"M Mochizuki","year":"1995","journal-title":"Biological & Pharmaceutical Bulletin"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1097\/00029330-200808010-00012","article-title":"Inhibitory effect of ginsenoside Rg3 on ovarian cancer metastasis","volume":"121","author":"TM Xu","year":"2008","journal-title":"Chin Med J (Engl)"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/00029330-200704010-00011","article-title":"Inhibitory effect of ginsenoside Rg3 combined with cyclophosphamide on growth and angiogenesis of ovarian cancer","volume":"120","author":"TM Xu","year":"2007","journal-title":"Chin Med J (Engl)"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1055\/s-2006-931563","article-title":"Ginsenosides Rg3 and Rh2 inhibit the activation of AP-1 and protein kinase A pathway in lipopolysaccharide\/interferon-gamma-stimulated BV-2 microglial cells","volume":"72","author":"EA Bae","year":"2006","journal-title":"Planta medica"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0027-5107(02)00323-8","article-title":"Inhibitory effects of the ginsenoside Rg3 on phorbol ester-induced cyclooxygenase-2 expression, NF-kappaB activation and tumor promotion","volume":"523\u2013524","author":"YS Keum","year":"2003","journal-title":"Mutation research"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e68771","DOI":"10.1371\/journal.pone.0068771","article-title":"Electrospun poly(L-lactide) fiber with ginsenoside rg3 for inhibiting scar hyperplasia of skin","volume":"8","author":"W Cui","year":"2013","journal-title":"PLoS One"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.bcp.2006.04.034","article-title":"The angiosuppressive effects of 20(R)- ginsenoside Rg3","volume":"72","author":"PY Yue","year":"2006","journal-title":"Biochemical pharmacology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"268","DOI":"10.2174\/156800910791190175","article-title":"Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer","volume":"10","author":"N Ahmed","year":"2010","journal-title":"Curr Cancer Drug Targets"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.2174\/138945012803530044","article-title":"Targeting pathways contributing to epithelial-mesenchymal transition (EMT) in epithelial ovarian cancer","volume":"13","author":"RY Huang","year":"2012","journal-title":"Curr Drug Targets"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.addr.2009.01.006","article-title":"The HIF-1-active microenvironment: an environmental target for cancer therapy","volume":"61","author":"S Kizaka-Kondoh","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"GL Semenza","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1158\/1535-7163.MCT-12-0054","article-title":"Sensitization of TRAIL-Induced Cell Death by 20(S)-Ginsenoside Rg3 via CHOP-Mediated DR5 Upregulation in Human Hepatocellular Carcinoma Cells","volume":"12","author":"JY Lee","year":"2013","journal-title":"Molecular Cancer Therapeutics"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2009.12.018","article-title":"Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-kappaB","volume":"631","author":"SM Kim","year":"2010","journal-title":"European journal of pharmacology"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"e41586","DOI":"10.1371\/journal.pone.0041586","article-title":"Natural product ginsenoside 25-OCH3-PPD inhibits breast cancer growth and metastasis through down-regulating MDM2","volume":"7","author":"W Wang","year":"2012","journal-title":"Plos One"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jep.2008.11.020","article-title":"Ginsenoside Rg1, a major active component isolated from Panax notoginseng, restrains tubular epithelial to myofibroblast transition in vitro","volume":"122","author":"XS Xie","year":"2009","journal-title":"Journal of ethnopharmacology"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s11418-011-0609-8","article-title":"Red ginseng and 20(S)-Rg3 control testosterone-induced prostate hyperplasia by deregulating androgen receptor signaling","volume":"66","author":"JS Bae","year":"2012","journal-title":"J Nat Med"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0103887","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T17:37:34Z","timestamp":1588959454000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0103887"}},"subtitle":[],"editor":[{"given":"Joseph","family":"Najbauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,9,8]]},"references-count":45,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2014,9,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0103887","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,8]]}}}